Indaptus Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Columbus Cir Fl 15, New York City, New...Phone Number
(646) 427-2727Website
www.indaptusrx.comRevenue
-Stock Symbol
INDPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
1
1
1
About Indaptus Therapeutics
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company based in New York City, focused on developing innovative immunotherapies for cancer and infectious diseases. The company's approach leverages the body's innate and adaptive immune systems by utilizing engineered, non-pathogenic gram-negative bacteria to activate multiple immune pathways.Explore more
Indaptus Therapeutics Org Chart
JM
Co-Chief Executive Officer
YD
Chief Financial Officer
DL
Co-Chief Executive Officer & Chairman of the ...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Indaptus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Indaptus Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Indaptus Therapeutics
Funding: Get notified immidiatlly once Indaptus Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Indaptus Therapeutics is spiking on competitors!
Product Launch: Get notified when Indaptus Therapeutics launches new products
Earning: See what the market has to say on Indaptus Therapeutics recently announced quarterly report
Indaptus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Indaptus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Indaptus Therapeutics
Compare insights from companies similar to Indaptus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Indaptus Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Indaptus Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Indaptus Therapeutics.
Indaptus Therapeutics financials insights
Gather financial insights about Indaptus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$2.3M
Indaptus Therapeutics Tech Stack
A closer look at the technologies used by Indaptus Therapeutics
See more technologies
Most Recent Scoops
Earnings
Earnings, Finance
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Indaptus Therapeutics
Sign Up For FreeTo access detailed company insights
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company based in New York City, focused on developing innovative immunotherapies for cancer and infectious diseases. The company's approach leverages the body's innate and adaptive immune systems by utilizing engineered, non-pathogenic gram-negative bacteria to activate multiple immune p... Read More
